Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2185-2190

  Chen, Ya Xi ^a   Ruan, Xiong Zhong ^a   Huang, Ai Long ^a   Li, Qiu ^a   Moorhead, John F ^b   Varghese, Zac ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cholesterol; Cytokines; Low density lipoprotein receptor; SREBP cleavage activating protein; Sterol regulatory element binding protein 2

Indexed keywords

CELL PROTEIN; CHOLESTEROL; CHOLESTEROL ESTER; CYTOKINE; FAT DROPLET; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PROTEIN ANTIBODY; RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROL REGULATORY ELEMENT BINDING PROTEIN CLEAVAGE ACTIVATING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; ENDOPLASMIC RETICULUM; ENZYME ASSAY; FEEDBACK SYSTEM; GENE OVEREXPRESSION; GOLGI COMPLEX; HUMAN; HUMAN CELL; INFLAMMATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 38349135392     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00005     Document Type: Article

References (23)

1. Goldstein JL, Brown MS. The LDL receptor and the regulation of cellular cholesterol metabolism. J Cell Sci Suppl 1985; 3: 131-137.
2. Wang X, Briggs MR, Yokoyama C, Goldstein JL, Brown MS. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter, II: purification and characterization. J Biol Chem 1993; 268: 14497-14504.
3. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993; 75: 187-197.
4. Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane bound transcription factor released by sterol-regulated proteolysis. Cell 1994; 77: 53-62.
5. Sanchez HB, Yieh L, Osborne TF. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J Biol Chem 1995; 270: 1161-1169.
6. Yang T, Goldstein JL, Brown MS. Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP/SREBP exit from endoplasmic reticulum. J Biol Chem 2000; 275: 29881-29886.
7. Sakai J, Rawson RB. The sterol regulatory element-protein pathway: control of lipid homeostasis through regulated intracellular transport. Curr Opin Lipidol 2001; 12: 261-266.
8. Goldstein JL, Rawson RB, Brown MS. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys 2002; 397: 139-148.
9. Norturfft A, DeBose-Boyd RA, Scheek S, Goldstein JL, Brown MS. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci U S A 1999; 96: 11235-11240.
10. Brown MS, Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 1999; 96: 11041-11048.
11. Nohturfft A, Yabe D, Goldstein JL, Brown MS, Espenshade PJ. Regulated step in cholesterol feedback localized to budding of SCAP from ER membrane. Cell 2000; 102: 315-323.
12. Ruan XZ, Varghese Z, Powis SH, Moorhead JF. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int 2001; 60: 1716-1725.
13. Ruan XZ, Moorhead JF, Tao JL, Ma KL, Wheeler DC, Powis SH, et al. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 2006; 26: 1150-1155.
14. Stopeck AT, Nicholson AC, Mancini FP, Hajjar DP. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 1993; 268: 17489-17494.
15. Levy E, Gurbindo C, Lacaille F, Paradis K, Thibault L, Seidman E. Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis. Pediatr Res 1993; 34: 162-166.
16. Hermus AR, Sweep CG, Demacker PN, van der Meer MJ, Kloppenborg PW, van der Meer JW. Continuous infusion of interleukin-1 beta in rats induces a profound fall in plasma levels of cholesterol and triglycerides. Arterioscler Thromb 1992; 12: 1036-1043.
17. Navarro MA, Carpintero R, Acin S, Arbones-Mainar JM, Calleja L, Carnicer R, et al. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine 2005; 31: 52-63.
18. Zykova SN, Svartberg J, Seljelid R, Iversen H, Lund A, Svistounov DN, et al. Release of TNF-alpha from in vitro-stimulated monocytes is negatively associated with serum levels of apolipoprotein B in patients with type 2 diabetes. Scand J Immunol 2004; 60: 535-542.
19. Chenaud C, Merlani PG, Roux-Lombard P, Burger D, Harbarth S, Luyasu S, et al. Low apolipoprotein A-1 level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med 2004; 32: 632-637.
20. Angelin B. Regulation of hepatic cholesterol metabolism in man. Ann Med 1991; 23: 177-180.
21. Rudling MJ, Reihner E, Einarsson K, Ewerth S, Angelin B. Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc Natl Acad Sci U S A 1990; 87: 3469-3473.
22. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
23. Smith JR, Osborne TF, Goldstein JL, Brown MS. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J Biol Chem 1990; 265: 2306-2310.